Target intelligence / Profile preview

Skeletal muscle fiber sarcolemma

Molecular classification
Cellular structure, Plasma membrane
01

Overview

The skeletal muscle fiber sarcolemma is the specialized plasma membrane of a muscle cell, serving as a critical barrier and signaling hub (StatPearls, 2023). It is essential for excitation-contraction coupling, housing voltage-gated ion channels and the nicotinic acetylcholine receptor (PubMed, PMID: 25635954). The sarcolemma is reinforced by the dystrophin-glycoprotein complex, which maintains structural integrity during muscle contraction; defects in this complex lead to Duchenne muscular dystrophy (NIH, 2022). While the sarcolemma itself is a cellular structure rather than a single molecular target, it contains numerous proteins that are primary targets for neuromuscular blockers, local anesthetics, and anti-myasthenic agents (PubChem). Damage to the sarcolemma results in the release of biomarkers like creatine kinase into the bloodstream, indicating muscle injury or disease (Mayo Clinic, 2023). Pharmacological intervention often focuses on stabilizing this membrane or modulating the activity of its embedded proteins to treat neuromuscular and cardiovascular conditions.

Other names
SarcolemmaMuscle cell membraneMyolemma
02

Mechanism of action

Drugs typically target specific proteins embedded within the sarcolemma, such as nicotinic acetylcholine receptors or voltage-gated ion channels, to modulate muscle excitability and contraction (StatPearls, 2023).

03

Biological functions

Excitation-contraction couplingIon transportSignal transductionStructural integrity
04

Disease associations

Muscular dystrophyMyasthenia gravisChannelopathiesRhabdomyolysis
05

Safety considerations

Malignant hyperthermiaRhabdomyolysisElectrolyte imbalance
06

Interacting drugs

Succinylcholine

3 more in the full profile.

07

Biomarkers

Creatine kinaseMyoglobinLactate dehydrogenase

Beyond the preview

Go deeper on Skeletal muscle fiber sarcolemma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skeletal muscle fiber sarcolemma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call